Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Biosimilars
Biosimilars
Page 2 of 2
Health
TPP trade deal: Even more bad news for biotech industry
By
Laura Lorenzetti
October 5, 2015
Finance
Hospira hit with further FDA scrutiny after $17 billion Pfizer deal
By
Laura Lorenzetti
April 8, 2015
Features
FDA approves the first biosimilar for the U.S. market
By
Laura Lorenzetti
March 6, 2015
Features
Biosimilars may one day save your life. But what are they?
By
Laura Lorenzetti
February 6, 2015
Most Popular
Success
MacKenzie Scott has donated more than $19 billion—but it's barely made a dent in her net worth because of the power of...
By
Sydney Lake
Environment
Elon Musk’s Boring Company fined nearly $500K after it dumped drilling fluids into Las Vegas manholes—then ‘feigned...
By
Jessica Mathews
and
Leo Schwartz
Success
Netflix cofounder says he stopped work at 5 p.m. every Tuesday for 30 years to stay ‘sane,’ no matter the crisis:...
By
Emma Burleigh
